Pfizer and BioNTech will test an omicron-specific version of their vaccine and a fourth shot of the original vaccine to determine the best path forward.
Pfizer and BioNTech begin testing omicron-specific vaccine on adults
Pfizer and BioNTech will test an omicron-specific version of their vaccine and a fourth shot of the original vaccine to determine the best path forward.